Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Current Assets: 2012-2025

Historic Current Assets for Ascendis Pharma A (ASND) over the last 11 years, with Sep 2025 value amounting to $1.2 billion.

  • Ascendis Pharma A's Current Assets rose 11.26% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 11.26%. This contributed to the annual value of $1.1 billion for FY2024, which is 51.86% up from last year.
  • Per Ascendis Pharma A's latest filing, its Current Assets stood at $1.2 billion for Q3 2025, which was up 10.30% from $1.1 billion recorded in Q2 2025.
  • Ascendis Pharma A's Current Assets' 5-year high stood at $1.3 billion during Q1 2022, with a 5-year trough of $675.6 million in Q2 2024.
  • Over the past 3 years, Ascendis Pharma A's median Current Assets value was $869.2 million (recorded in 2023), while the average stood at $909.0 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 68.66% in 2022, then plummeted by 37.81% in 2023.
  • Over the past 5 years, Ascendis Pharma A's Current Assets (Quarterly) stood at $921.9 million in 2021, then increased by 2.20% to $942.2 million in 2022, then fell by 19.75% to $756.1 million in 2023, then skyrocketed by 49.93% to $1.1 billion in 2024, then climbed by 11.26% to $1.2 billion in 2025.
  • Its Current Assets stands at $1.2 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $969.3 million for Q1 2025.